Literature DB >> 29246562

Crohn's disease.

María Pilar Ballester Ferré1, Marta Maia Boscá-Watts2, Miguel Mínguez Pérez2.   

Abstract

Crohn's disease is a chronic inflammatory bowel disease of unknown etiology associated with an impaired immune response, with periods of activity and remission. It is characterised by patchy and transmural lesions which can affect the entire gastrointestinal tract, from the mouth to the anus. The most frequent symptoms are abdominal pain and diarrhoea, which can seriously affect patients' quality of life. The increasing incidence and prevalence of the disease in our area has had a large impact on clinical practice, with the rapid development of diagnostic and therapeutic techniques. To reduce the risk of complications, primary care physicians and gastroenterologists should be familiar with the management of the disease.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Diagnostic-therapeutic management; Enfermedad de Crohn; Enfermedad inflamatoria intestinal; Inflammatory bowel disease; Manejo diagnóstico-terapéutico

Mesh:

Year:  2017        PMID: 29246562     DOI: 10.1016/j.medcli.2017.10.036

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  7 in total

1.  LINC01272 activates epithelial-mesenchymal transition through miR-153-5p in Crohn's disease.

Authors:  Lin Fang; Mengcheng Hu; Fei Xia; Wenxia Bai
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

2.  Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.

Authors:  Ke Qian; Lianwen Yuan; Shalong Wang; Yong Kuang; Qianqian Jin; Dongju Long; Yuhong Jiang; Hua Zhao; Kuijie Liu; Hongliang Yao
Journal:  Clin Exp Immunol       Date:  2021-06-07       Impact factor: 5.732

3.  Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review.

Authors:  Yantian Cao; Qi Su; Bangjie Zhang; Fangfang Shen; Shaoshan Li
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

Review 4.  The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence.

Authors:  S Ingallinella; M Campanelli; A Antonelli; C Arcudi; V Bellato; A Divizia; M Franceschilli; L Petagna; B Sensi; S Sibio; L Siragusa; G S Sica
Journal:  Gastroenterol Res Pract       Date:  2020-12-28       Impact factor: 2.260

Review 5.  Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population.

Authors:  Giulio Pulvirenti; Vincenzo Sortino; Sara Manti; Giuseppe Fabio Parisi; Maria Papale; Alessandro Giallongo; Salvatore Leonardi
Journal:  Ital J Pediatr       Date:  2022-09-11       Impact factor: 3.288

6.  Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models.

Authors:  Vishnu Raj; Balaji Venkataraman; Saeeda Almarzooqi; Sanjana Chandran; Shreesh K Ojha; Samir Attoub; Thomas E Adrian; Sandeep B Subramanya
Journal:  Nutrients       Date:  2020-07-08       Impact factor: 5.717

Review 7.  Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases.

Authors:  Naschla Gasaly; Marcela A Hermoso; Martín Gotteland
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.